Psychedelic-Assisted Therapy
An interview with Dr. Craig Heacock, M.D., about innovative treatments in psychiatry. Curt and Katie talk with Dr. Heacock about psychedelic-assisted therapy – looking at efficacy, safety, and risks for these promising treatments (ketamine, psilocybin, and MDMA) for depression and trauma. We also discuss the debate about medicalization versus legalization of these substances.
It’s time to reimagine therapy and what it means to be a therapist. To support you as a whole person and a therapist, your hosts, Curt Widhalm and Katie Vernoy talk about how to approach the role of therapist in the modern age.
Interview with Dr. Craig Heacock, M.D.
Dr. Craig Heacock is an adolescent/adult psychiatrist and addiction specialist in Colorado as well as the co-producer and host of the psychiatric storytelling podcast Back from the Abyss. He was a therapist in the Phase 3 trial of MDMA-Assisted Psychotherapy for PTSD and has particular interest in the use of ketamine and other psychedelics to treat severe mood disorders and PTSD. He is a graduate of the University of New Mexico School of Medicine and did his psychiatry training at Brown University.
In this episode we talk about:
The innovations in psychedelic-assisted therapy
Why it is so hard to find a good psychiatrist, especially one that goes beyond med checks
How psychiatry is changing, as well as how little has changed in medication since 1994
Treatment-resistant may mean deep-seated trauma
Definitions of psychedelics, psychedelic-assisted treatment
Ketamine, MDMA, psilocybin
Efficacy for treatment with ketamine, MDMA, psilocybin for trauma and depression
The speed of building trust and moving into the working phase with these treatments
Safety concerns and side effects with ketamine, psilocybin, and MDMA
Boundaries and safety for therapists (as well as clients) during these treatments
The vulnerability during these treatments
Self-assessment for mental health providers whether they should work in this space
The importance of doing your own psychedelic treatment before being a therapist in this work
Client-perceptions of clinicians doing their own psychedelic work (or publicly owning their story)
The increasing acceptance of these types of treatments – the treatments becoming more mainstream
Psilocybin – in trials for FDA approval for trauma treatment, but may be legalized before it is medicalized and used for treatment
Medicalization versus legalization conversation
The problems with medical THC (including making symptoms worse and psychotic breaks)
Micro-dosing efficacy and risks and whether they should be managed by a doctor
The importance of assessing sleep and substance use/abuse
Abyss stories – how Dr. Heacock started telling these stories and the power of these stories
Resources mentioned:
We’ve pulled together resources mentioned in this episode and put together some handy-dandy links. Please note that some of the links below may be affiliate links, so if you purchase after clicking below, we may get a little bit of cash in our pockets. We thank you in advance!
Craig Heacock, MD Website
Back from the Abyss Podcast
Interview with Lisa Ling
Laura Northrup Inside Eyes Podcast
Article: Self-admitted psychedelic use and association with psychedelic culture harm perceptions of researchers’ scientific integrit
